EX-99.A 2 d647575dex99a.htm EXHIBIT A Exhibit A

Exhibit A

TRANSACTIONS DURING PAST 60 DAYS

The Reporting Persons engaged in the following transactions in shares of common stock of the Issuer during the past 60 days:

 

Reporting Person

   Date of
Transaction
   Transaction Type
(Purchase or Sale)
   Shares     Price/Share  

Capital Royalty Partners II L.P.

   11/16/2018    Purchase      4,224,605       * ** 

Capital Royalty Partners II (Cayman) L.P.

   11/16/2018    Purchase      1,264,997       * ** 

Capital Royalty Partners II Parallel Fund “A” L.P.

   11/16/2018    Purchase      7,427,065       * ** 

Capital Royalty Partners II Parallel Fund “B” (Cayman) L.P.

   11/16/2018    Purchase      2,083,333       * ** 

Capital Royalty Partners II L.P.

   11/16/2018    Purchase      4,224,605     * ** 

Capital Royalty Partners II (Cayman) L.P.

   11/16/2018    Purchase      1,264,997     * ** 

Capital Royalty Partners II Parallel Fund “A” L.P.

   11/16/2018    Purchase      7,427,065     * ** 

Capital Royalty Partners II Parallel Fund “B” (Cayman) L.P.

   11/16/2018    Purchase      2,083,333     * ** 

Capital Royalty Partners II L.P.

   11/16/2018    Purchase      4,224,605 **      * ** 

Capital Royalty Partners II (Cayman) L.P.

   11/16/2018    Purchase      1,264,997 **      * ** 

Capital Royalty Partners II Parallel Fund “A” L.P.

   11/16/2018    Purchase      7,427,065 **      * ** 

Capital Royalty Partners II Parallel Fund “B” (Cayman) L.P.

   11/16/2018    Purchase      2,083,333 **      * ** 

 

*

Represents shares of common stock of the Issuer underlying Series A warrants, each of which became exercisable for one share of the Issuer’s common stock immediately upon issuance, and expires on November 16, 2023.

**

Represents shares of common stock of the Issuer underlying Series B warrants, each of which became exercisable for one share of the Issuer’s common stock immediately upon issuance, and expires on November 16, 2023.

***

Shares were purchased in the November 2018 Public Offering. Each share of common stock of the Issuer was sold together with a Series A warrant and a Series B warrant for $0.48.